Quantcast

Latest Bronchial Thermoplasty Stories

2011-05-16 11:45:00

NATICK, Mass. and DENVER, May 16, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced long-term safety data from the Research in Severe Asthma (RISA) Trial, which demonstrated the maintenance of stable lung function and the absence of clinical complications over a five-year period in patients with severe refractory asthma treated with its Alair(®) Bronchial Thermoplasty System. The RISA Trial is the third in a series of clinical trials that...

2010-11-02 07:30:00

NATICK, Mass. and VANCOUVER, Nov. 2, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that its newly acquired subsidiary, Asthmatx, Inc., presented two-year results from the Asthma Intervention Research 2 (AIR2) Trial demonstrating the long-term safety and effectiveness of bronchial thermoplasty (BT) in adult patients with severe asthma. Results were presented by Mario Castro, M.D., Professor of Medicine and Pediatrics, Washington University School...

2010-09-08 08:57:05

(Ivanhoe Newswire) -- Researchers say as many as 50 percent treatment-resistant asthma cases in kids are misdiagnosed.  Many children will respond to therapy if managed properly, according to new studies. Research shows many cases of apparently treatment-resistant asthma happen because of poor management of the basics including adherence to treatment, inhaler technique, dose and frequency, and minimization of exposure to environmental triggers such as allergens and smoke. Study authors...

2010-05-19 15:39:00

NEW ORLEANS, May 19 /PRNewswire/ -- Asthmatx Inc., today presented positive five-year data from the Asthma Intervention Research (AIR) Trial, which evaluated the safety of bronchial thermoplasty (BT) with the Alair® System. The data demonstrated the absence of clinical complications and the maintenance of stable lung function over a five year period post-BT in patients with moderate to severe asthma. The data was presented in a poster at the annual meeting of the American...

2010-05-19 08:15:00

NEW ORLEANS, May 19 /PRNewswire/ -- Asthmatx Inc., today presented positive five-year data from the Asthma Intervention Research (AIR) Trial, which evaluated the safety of bronchial thermoplasty (BT) with the Alair® System. The data demonstrated the absence of clinical complications and the maintenance of stable lung function over a five year period post-BT in patients with moderate to severe asthma. The data was presented in a poster at the annual meeting of the American...

2010-05-10 07:30:00

SUNNYVALE, Calif., May 10 /PRNewswire/ -- Asthmatx, Inc. reported today that doctors at Virginia Hospital Center in Arlington, Va., recently treated the first U.S. patient with bronchial thermoplasty (BT) delivered by the Alair® System, the first device-based asthma treatment approved by the U.S. Food and Drug Administration (FDA). The novel outpatient procedure delivers controlled thermal energy to reduce excess airway smooth muscle that is associated with airway...

f43f212935dac8267516120f04f2ae7f1
2010-05-05 06:10:00

People that suffer from asthma are getting a radically different treatment option by having a wire snaked inside their lungs to melt off some of the tissue that squeezes their airway shut. The bronchial thermoplastic treatment is being released this month and offers the first method of physically altering spasm-prone airways. "It does seem to improve your ability to live with your asthma," Dr. Michael Silver of Chicago's Rush University Medical Center, told the Associated Press. "I...

2010-05-03 16:20:00

Novel Procedure for Long Lasting Control of Severe Asthma ARLINGTON, Va., May 3 /PRNewswire-USNewswire/ -- Virginia Hospital Center announced today that it will be the first Hospital in the United States to offer a new procedure for severe asthma patients known as bronchial thermoplasty. The Alair® Bronchial Thermoplasty System was recently approved by the U.S. Food and Drug Administration (FDA). Patients who are 18 years and older and suffer from severe persistent...

2010-04-27 20:10:00

SUNNYVALE, Calif., April 27 /PRNewswire/ -- Asthmatx Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved the Alair® Bronchial Thermoplasty System for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long acting beta agonists, the current standard-of-care treatment for these patients. To view the multimedia assets associated with this release,...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related